Scinovex
articleTop 1% cited

Clinical End Points in Coronary Stent Trials

Circulation · 2007 · Vol. 115(17) · pp. 2344–2351
Donald E. CutlipStephan WindeckerRoxana MehranAshley B. BoamDavid J. CohenGerrit‐Anne van EsPhilippe Gabríel StegMarie‐Angèle MorelLaura MauriPascal VranckxEugène McFaddenAlexandra J. LanskyMartial HamonMitchell W. KrucoffPatrick W. Serruys

Abstract

Although consensus criteria will inevitably include certain arbitrary features, consensus criteria for clinical end points provide consistency across studies that can facilitate the evaluation of safety and effectiveness of these devices.

Coronary Interventions and DiagnosticsCardiac Imaging and DiagnosticsHealth Systems, Economic Evaluations, Quality of LifeMedicineFood and drug administrationClinical trialConsistency (knowledge bases)End pointClinical endpointEndpoint DeterminationStentIntensive care medicineSurgery

MeSH terms

Clinical Trials as TopicCoronary DiseaseHumansThrombosisStentsDrug Delivery SystemsCoronary Restenosis
Citations
5,387
FWCI
187.13
field-weighted impact
References
45
Percentile
100%
vs. same field & year
Citations per year
Cited by
Third Universal Definition of Myocardial Infarction
Circulation · 2012 · 2,947 citations
Third universal definition of myocardial infarction
European Heart Journal · 2012 · 3,055 citations
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
New England Journal of Medicine · 2009 · 7,018 citations
Third Universal Definition of Myocardial Infarction
Journal of the American College of Cardiology · 2012 · 2,620 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Clinical End Points in Coronary Stent Trials · Scinovex